Page last updated: 2024-08-21

levonorgestrel and Vascular Diseases

levonorgestrel has been researched along with Vascular Diseases in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19903 (27.27)18.7374
1990's4 (36.36)18.2507
2000's2 (18.18)29.6817
2010's1 (9.09)24.3611
2020's1 (9.09)2.80

Authors

AuthorsStudies
De Martino, M; Govind, A1
Hugon-Rodin, J; Plu-Bureau, G; Sabbagh, E1
Rozenbaum, H1
Abed, A; Chelli, H; Habibi, H; Khrouf, M; Messaad, J; Ouerghemmi, R; Rouis, M; Sfar, E; Zouari, F1
Maclennan, AH1
Ishak, R1
Ahmad, R; Ang, ES; Gudum, HR; Hassan, K; Ishak, R1
Kaplan, PF; Meendering, JR; Minson, CT; Torgrimson, BN1
Dwarte, D; Fraser, IS; Hickey, M1

Trials

1 trial(s) available for levonorgestrel and Vascular Diseases

ArticleYear
Endothelial function across an oral contraceptive cycle in women using levonorgestrel and ethinyl estradiol.
    American journal of physiology. Heart and circulatory physiology, 2007, Volume: 292, Issue:6

    Topics: Adult; Blood Pressure; Brachial Artery; Contraceptives, Oral, Combined; Drug Administration Schedule; Endothelium, Vascular; Estrogens; Ethinyl Estradiol; Female; Heart Rate; Humans; Levonorgestrel; Nitroglycerin; Progestins; Reference Values; Risk Assessment; Vascular Diseases; Vasodilation; Vasodilator Agents

2007

Other Studies

10 other study(ies) available for levonorgestrel and Vascular Diseases

ArticleYear
SCAD: a gendered cardiac threat.
    Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2020, Volume: 40, Issue:7

    Topics: Adult; Clomiphene; Contraception; Contraceptives, Oral; Coronary Vessel Anomalies; Estrogen Replacement Therapy; Estrogens; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy Complications, Cardiovascular; Progesterone; Vascular Diseases

2020
[Hormonal contraception and vascular risk: CNGOF Contraception Guidelines].
    Gynecologie, obstetrique, fertilite & senologie, 2018, Volume: 46, Issue:12

    Topics: Androstenes; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Desogestrel; Female; France; Humans; Levonorgestrel; Norpregnenes; Progestins; Risk Factors; Vascular Diseases; Venous Thromboembolism

2018
[Progestins and arterial disease].
    Contraception, fertilite, sexualite, 1985, Volume: 13, Issue:1 Suppl

    Topics: Age Factors; Behavior; Biology; Blood; Blood Coagulation; Carbohydrates; Cardiovascular System; Cause of Death; Cholesterol; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Demography; Disease; Endocrine System; Ethinyl Estradiol; Family Planning Services; Glucose; Hormones; Levonorgestrel; Lipids; Metabolism; Mortality; Norethindrone; Organic Chemicals; Physiology; Population; Population Characteristics; Reproductive Control Agents; Smoking; Social Behavior; Vascular Diseases

1985
[Norplant contraception at the Rabta Tunis maternity hospital].
    Contraception, fertilite, sexualite, 1994, Volume: 22, Issue:4

    Topics: Africa; Africa, Northern; Biology; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Developing Countries; Diabetes Mellitus; Disease; Family Planning Services; Heart Diseases; Hypertension; Lactation; Levonorgestrel; Menstruation Disturbances; Middle East; Physiology; Pregnancy; Prospective Studies; Research; Risk Factors; Tunisia; Vascular Diseases

1994
Oral contraceptives.
    Current therapeutics, 1987, Volume: 28, Issue:12

    Topics: Age Factors; Behavior; Biology; Breast Feeding; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Postcoital; Demography; Disease; Embolism; Endocrine System; Ethinyl Estradiol; Family Planning Services; Health; Heart Diseases; Hormones; Hypertension; Infant Nutritional Physiological Phenomena; Levonorgestrel; Liver Diseases; Mestranol; Morbidity; Mortality; Norethindrone; Nutritional Physiological Phenomena; Physiology; Population; Population Characteristics; Population Dynamics; Progesterone; Progestins; Smoking; Thromboembolism; Vascular Diseases

1987
Effect of combined low-dose oral contraceptives on blood viscosity and haematocrit.
    Malaysian journal of reproductive health : a publication of the Reproductive Research Centre of the National Population and Family Development Board, Malaysia, 1991, Volume: 9, Issue:1

    Topics: Asia; Asia, Southeastern; Biology; Blood; Blood Coagulation; Case-Control Studies; Clinical Laboratory Techniques; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Sectional Studies; Desogestrel; Developing Countries; Diagnosis; Disease; Embolism; Ethinyl Estradiol; Family Planning Services; Hematocrit; Hematologic Tests; Levonorgestrel; Malaysia; Methods; Physiology; Research; Research Design; Thromboembolism; Thrombosis; Vascular Diseases

1991
Pill research results in new guidance from CSM.
    Family planning today, 1995

    Topics: Biology; Communication; Consumer Product Safety; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Delivery of Health Care; Demography; Desogestrel; Developed Countries; Disease; Embolism; Europe; Evaluation Studies as Topic; Family Planning Services; Geography; Health; Health Personnel; Knowledge; Levonorgestrel; Norethindrone; Population; Public Health; Residence Characteristics; Risk Assessment; Risk Factors; Safety; Thromboembolism; Thrombosis; United Kingdom; Vascular Diseases

1995
Norgestrel, increased lipids: fact or "marketing monster"?
    Contraceptive technology update, 1989, Volume: 10, Issue:10

    Topics: Americas; Arterial Occlusive Diseases; Arteriosclerosis; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Developed Countries; Disease; Ethinyl Estradiol; Family Planning Services; Levonorgestrel; Lipids; Norethindrone; Norgestrel; North America; Physiology; United States; Vascular Diseases

1989
Fibrinolytic response in women on low-dose oral contraceptive.
    Malaysian journal of reproductive health : a publication of the Reproductive Research Centre of the National Population and Family Development Board, Malaysia, 1992, Volume: 10, Issue:1

    Topics: Asia; Asia, Southeastern; Biology; Blood; Blood Coagulation; Clinical Laboratory Techniques; Clinical Trials as Topic; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Developing Countries; Diagnosis; Disease; Embolism; Family Planning Services; Fibrinolysis; Hematologic Tests; Levonorgestrel; Malaysia; Physiology; Research; Thromboembolism; Thrombosis; Vascular Diseases

1992
Superficial endometrial vascular fragility in Norplant users and in women with ovulatory dysfunctional uterine bleeding.
    Human reproduction (Oxford, England), 2000, Volume: 15, Issue:7

    Topics: Adult; Contraceptive Agents, Female; Endometrium; Female; Humans; Hysteroscopy; Levonorgestrel; Menorrhagia; Menstruation; Ovulation; Prospective Studies; Uterine Hemorrhage; Vascular Diseases

2000